Skip to Content

Drug Interactions between Ogivri and Propulsid

This report displays the potential drug interactions for the following 2 drugs:

  • Ogivri (trastuzumab)
  • Propulsid (cisapride)

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Ogivri and Propulsid. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Ogivri

A total of 125 drugs are known to interact with Ogivri.

Propulsid

A total of 323 drugs are known to interact with Propulsid.

Drug and food interactions

Major

cisapride food

Applies to: Propulsid (cisapride)

Cisapride is no longer on the market in the US. Do not take cisapride with any other medication, food, or beverage.

**Cisapride (Propulsid) is no longer marketed in the United States. You should only be taking cisapride if you are obtaining the medication from your doctor though a Limited Access Program developed jointly by the manufacturer and the FDA.**

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.